Patent Pool Welcomes Long-Acting Injectables License
Tandem Nano Deal Offers Technologies For Malaria, Tuberculosis And Hepatitis C
The Medicines Patent Pool has struck a deal with University of Liverpool start-up Tandem Nano to secure its first license for long-acting technologies for malaria, tuberculosis, and hepatitis C.
You may also be interested in...
A continuing lack of legal certainty continues to plague suppliers to the Northern Ireland market despite the latest proposals from the EU Commission, UK and European off-patent industry leaders Mark Samuels and Adrian van den Hoven tell Generics Bulletin.
With multiple US biosimilar applications held up by the FDA’s inability to conduct necessary inspections in the context of the COVID-19 pandemic, the agency tells Generics Bulletin that it is “actively working” on a solution.
Value-added medicines specialist Hyloris has announced launch plans for its Maxigesic IV analgesic in the UK and Ireland after receiving approvals for the intravenous paracetamol/ibuprofen solution. The nods follow two deals aimed at bolstering the firm’s pipeline.